|
1
|
Prevention CfDC a: Global Cancer
Statistics. Available from: http://www.cdc.gov/cancer/international/statistics.htm.
|
|
2
|
Organization WH: Human papillomavirus
(HPV) and cervical cancer [cited 2016 June 10]. Available from:
http://www.who.int/mediacentre/factsheets/fs380/en/.
|
|
3
|
Reducing uncertainties about the effects
of chemoradiotherapy for cervical cancer: Individual patient data
meta-analysis. The Cochrane database of systematic reviews.
2010.1:CD008285
|
|
4
|
Huang Z, Mayr NA, Yuh WT, Lo SS,
Montebello JF, Grecula JC, Lu L, Li K, Zhang H, Gupta N and Wang
JZ: Predicting outcomes in cervical cancer: A kinetic model of
tumor regression during radiation therapy. Cancer Res. 70:463–470.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang J, Yue JB, Liu J and Yu JM:
Repopulation of tumor cells during fractionated radiotherapy and
detection methods (Review). Oncol Lett. 7:1755–1760. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kwok ZH and Tay Y: Long noncoding RNAs:
Lincs between human health and disease. Biochem Soc Trans.
45:805–812. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Chen W, Yang C, Wu W, Wu S, Qin X
and Li X: Long non-coding RNA UCA1a(CUDR) promotes proliferation
and tumorigenesis of bladder cancer. Int J Oncol. 41:276–284.
2012.PubMed/NCBI
|
|
10
|
Xue M, Chen W and Li X: Urothelial cancer
associated 1: A long noncoding RNA with a crucial role in cancer. J
Cancer Res Clin Oncol. 142:1407–1419. 2016. View Article : Google Scholar
|
|
11
|
Fotouhi Ghiam A, Taeb S, Huang X, Huang V,
Ray J, Scarcello S, Hoey C, Jahangiri S, Fokas E, Loblaw A, et al:
Long non-coding RNA urothelial carcinoma associated 1 (UCA1)
mediates radiation response in prostate cancer. Oncotarget.
8:4668–4689. 2017.
|
|
12
|
Wang H, Guan Z, He K, Qian J, Cao J and
Teng L: LncRNA UCA1 in anti-cancer drug resistance. Oncotarget.
8:64638–64650. 2017.PubMed/NCBI
|
|
13
|
Zhao H, Jiang H, Li Z, Zhuang Y, Liu Y,
Zhou S, Xiao Y, Xie C, Zhou F and Zhou Y: 2-Methoxyestradiol
enhances radiosen-sitivity in radioresistant melanoma MDA-MB-435R
cells by regulating glycolysis via HIF-1alpha/PDK1 axis. Int J
Oncol. 50:1531–1540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shimura T, Noma N, Sano Y, Ochiai Y,
Oikawa T, Fukumoto M and Kunugita N: AKT-mediated enhanced aerobic
glycolysis causes acquired radioresistance by human tumor cells.
Radiother Oncol. 112:302–307. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Noordhuis MG, Eijsink JJ, Roossink F, de
Graeff P, Pras E, Schuuring E, Wisman GB, de Bock GH and van der
Zee AG: Prognostic cell biological markers in cervical cancer
patients primarily treated with (chemo)radiation: A systematic
review. Int J Radiat Oncol Biol Phys. 79:325–334. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jing Z, Gong L, Xie CY, Zhang L, Su HF,
Deng X and Wu SX: Reverse resistance to radiation in KYSE-150R
esophageal carcinoma cell after epidermal growth factor receptor
signal pathway inhibition by cetuximab. Radiother Oncol.
93:468–473. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods.
25:402–408. 2001. View Article : Google Scholar
|
|
19
|
Fang Y and Fullwood MJ: Roles, functions,
and mechanisms of long non-coding RNAs in cancer. Genomics
Proteomics Bioinformatics. 14:42–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu X, Jiang H and Jiang X: Downregulation
of lncRNA ANRIL inhibits proliferation, induces apoptosis, and
enhances radiosensitivity in nasopharyngeal carcinoma cells through
regulating miR-125a. Cancer Biol Ther. 18:331–338. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang H, Hu X, Zhang H and Li W:
Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder
cancer via suppressing HMGB1 expression. Radiat Oncol. 12:652017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Z, Zhou Y, Tu B, Bu Y, Liu A and Kong
J: Long noncoding RNA MALAT1 affects the efficacy of radiotherapy
for esophageal squamous cell carcinoma by regulating Cks1
expression. J Oral Pathol Med. 46:583–590. 2017. View Article : Google Scholar
|
|
23
|
Lu H, He Y, Lin L, Qi Z, Ma L, Li L and Su
Y: Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+
cervical cancer via sponging miR-145. Tumour Biol. 37:1683–1691.
2016. View Article : Google Scholar
|
|
24
|
Kondoh H, Lleonart ME, Gil J, Wang J,
Degan P, Peters G, Martinez D, Carnero A and Beach D: Glycolytic
enzymes can modulate cellular life span. Cancer Res. 65:177–185.
2005.PubMed/NCBI
|
|
25
|
Gatenby RA and Gillies RJ: Why do cancers
have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lall R, Ganapathy S, Yang M, Xiao S, Xu T,
Su H, Shadfan M, Asara JM, Ha CS, Ben-Sahra I, et al: Low-dose
radiation exposure induces a HIF-1-mediated adaptive and protective
metabolic response. Cell Death Differ. 21:836–844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhong JT and Zhou SH: Warburg effect,
hexokinase-II, and radioresistance of laryngeal carcinoma.
Oncotarget. 8:14133–14146. 2017.
|
|
28
|
Bhatt AN, Chauhan A, Khanna S, Rai Y,
Singh S, Soni R, Kalra N and Dwarakanath BS: Transient elevation of
glycolysis confers radio-resistance by facilitating DNA repair in
cells. BMC Cancer. 15:3352015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Khodarev NN, Beckett M, Labay E, Darga T,
Roizman B and Weichselbaum RR: STAT1 is overexpressed in tumors
selected for radioresistance and confers protection from radiation
in transduced sensitive cells. Proc Natl Acad Sci USA.
101:1714–1719. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pitroda SP, Wakim BT, Sood RF, Beveridge
MG, Beckett MA, MacDermed DM, Weichselbaum RR and Khodarev NN:
STAT1-dependent expression of energy metabolic pathways links
tumour growth and radioresistance to the Warburg effect. BMC Med.
7:682009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao Y, Wu F, Zhou J, Yan L, Jurczak MJ,
Lee HY, Yang L, Mueller M, Zhou XB, Dandolo L, et al: The H19/let-7
double-negative feedback loop contributes to glucose metabolism in
muscle cells. Nucleic Acids Res. 42:13799–13811. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng P, Xiong Q, Wu Y, Chen Y, Chen Z,
Fleming J, Gao D, Bi L and Ge F: Quantitative proteomics analysis
reveals novel insights into mechanisms of action of long noncoding
RNA Hox transcript antisense intergenic RNA (HOTAIR) in HeLa cells.
Mol Cell Proteomics. 14:1447–1463. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo F, Liu X, Ling M, Lu L, Shi L, Lu X,
Li J, Zhang A and Liu Q: The lncRNA MALAT1, acting through
HIF-1alpha stabilization, enhances arsenite-induced glycolysis in
human hepatic L-02 cells. Biochim Biophys Acta. 1862:1685–1695.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yu C, Xue J, Zhu W, Jiao Y, Zhang S and
Cao J: Warburg meets non-coding RNAs: The emerging role of ncRNA in
regulating the glucose metabolism of cancer cells. Tumour Biol.
36:81–94. 2015. View Article : Google Scholar
|
|
35
|
Li Z, Li X, Wu S, Xue M and Chen W: Long
non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase
2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci.
105:951–955. 2014. View Article : Google Scholar : PubMed/NCBI
|
